New Dimensions And Landmark Practice Advances In Comprehensive Cardiovascular Protection
Orlando, FL
Select Session
click below to choose a session for viewing for webcast help click here
Introduction
Program Chairman:
Matthew R.
Weir, MD
The Current Landscape of Cardiovascular Risk Management – The Co-Morbidity Continuum: Hypertension, CHD, Diabetes and Heart Failure
Matthew R.
Weir, MD
Mechanisms of End Organ Damage and Adverse Outcomes in the Patient with Hypertension — A Look Behind the Curtain and Beyond the Numbers
James
Ferguson III, MD, FACC
A Winning Combination – Applying Hypertension Treatment to Vascular Outcome Analysis: Evidence-Based Approaches Focusing on Combination Therapy and Compelling Conditions in the Setting of Heart Disease
Kenneth A.
Jamerson, MD
The Foundation Role of ARBs, Direct Renin Inhibitors and ACE Inhibitors for Vascular End Point Salvage: Focus on Diabetes, Ischemic Heart Disease and Renal Protection
Matthew R.
Weir, MD
Inhibiting the Renin Angiotensin System (RAS) – Lessons
Marc
Pfeffer, MD
